SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-18-000291
Filing Date
2018-01-09
Accepted
2018-01-09 06:34:57
Documents
1
Period of Report
2018-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-40679.html 4  
1 PRIMARY DOCUMENT marketforms-40679.xml 4 6469
  Complete submission text file 0001214659-18-000291.txt   7881
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Thompson David E. (Reporting) CIK: 0001484500 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 18517825